| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | WAPL ERCC6L MCM7 RECQL4 DDX12P MYO18A BTAF1 XRCC3 RFC5 DHX30 | 5.86e-07 | 127 | 199 | 10 | GO:0008094 |
| GeneOntologyMolecularFunction | ATP-dependent activity | WAPL MYO1D ERCC6L KIF12 MCM7 RECQL4 ATP11A DYNC1H1 VCP KIF22 DDX12P DNAH2 MYO18A BTAF1 XRCC3 RFC5 DHX30 MYO15A ATP2B1 | 1.32e-05 | 614 | 199 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC6L KIF12 MCM7 RECQL4 ATP11A DYNC1H1 VCP KIF22 DDX12P DNAH2 MYO18A BTAF1 RFC5 DHX30 ATP2B1 | 3.82e-05 | 441 | 199 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | lipid kinase activity | 5.23e-05 | 41 | 199 | 5 | GO:0001727 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate receptor activity | 5.26e-05 | 8 | 199 | 3 | GO:0038036 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | WAPL ERCC6L MCM7 RECQL4 DDX12P NTHL1 MYO18A BTAF1 XRCC3 RFC5 DHX30 | 6.72e-05 | 262 | 199 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | D-erythro-sphingosine kinase activity | 9.88e-05 | 2 | 199 | 2 | GO:0017050 | |
| GeneOntologyMolecularFunction | sphingosine kinase activity | 9.88e-05 | 2 | 199 | 2 | GO:0008481 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.82e-04 | 118 | 199 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.82e-04 | 62 | 199 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 4.96e-04 | 16 | 199 | 3 | GO:0045125 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | WAPL ERCC6L EARS2 MCM7 ANGEL2 RECQL4 TARS1 DDX12P IARS1 NTHL1 MYO18A BTAF1 XRCC3 RFC5 DHX30 TYW1 | 7.68e-04 | 645 | 199 | 16 | GO:0140640 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | USE1 BBS2 LMAN2L AP5Z1 AP1G2 VCP DOP1B TMED1 ANK1 COPB1 COPG1 MYO18A RNF139 DOP1A | 4.52e-06 | 339 | 195 | 14 | GO:0048193 |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 1.63e-05 | 6 | 195 | 3 | GO:0031581 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.35e-04 | 11 | 200 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | microtubule organizing center | AHI1 KIF12 BBS2 BIRC6 KAT2B SLMAP DIAPH1 NLRC5 DYNC1H1 DDX12P TBC1D30 HAP1 BRSK2 MYO18A ANKRD62 CCDC141 CCDC88C KIAA1217 RAB11FIP5 ATM PCNT | 2.05e-04 | 919 | 200 | 21 | GO:0005815 |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 1.32e-05 | 11 | 75 | 4 | HP:0032449 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 1.96e-05 | 12 | 75 | 4 | HP:0031538 | |
| HumanPheno | Alopecia of scalp | 4.30e-05 | 45 | 75 | 6 | HP:0002293 | |
| Domain | ARM-type_fold | SMG1 WAPL CAND1 CAND2 INTS1 CUL9 PSMD5 TELO2 PI4KA DIAPH1 AP1G2 BRAT1 IPO5 COPB1 COPG1 USP24 RANBP6 FRYL BTAF1 HUWE1 MROH1 PELP1 ATM | 1.48e-12 | 339 | 197 | 23 | IPR016024 |
| Domain | ARM-like | SMG1 CAND1 CAND2 CUL9 PSMD5 TELO2 AP5Z1 AP1G2 BRAT1 IPO5 COPB1 COPG1 RANBP6 FRYL BTAF1 HUWE1 MROH1 PELP1 | 5.99e-10 | 270 | 197 | 18 | IPR011989 |
| Domain | - | CAND1 CAND2 CUL9 PSMD5 TELO2 AP5Z1 AP1G2 BRAT1 IPO5 COPB1 COPG1 RANBP6 FRYL BTAF1 MROH1 | 1.43e-08 | 222 | 197 | 15 | 1.25.10.10 |
| Domain | HEAT_REPEAT | 5.02e-08 | 70 | 197 | 9 | PS50077 | |
| Domain | HEAT | 6.67e-07 | 48 | 197 | 7 | PF02985 | |
| Domain | HEAT | 2.49e-06 | 58 | 197 | 7 | IPR000357 | |
| Domain | Cullin_CS | 3.92e-05 | 7 | 197 | 3 | IPR016157 | |
| Domain | Cullin_neddylation_domain | 6.22e-05 | 8 | 197 | 3 | IPR019559 | |
| Domain | Cullin_Nedd8 | 6.22e-05 | 8 | 197 | 3 | PF10557 | |
| Domain | Cullin_Nedd8 | 6.22e-05 | 8 | 197 | 3 | SM00884 | |
| Domain | Cullin_homology | 9.26e-05 | 9 | 197 | 3 | IPR016158 | |
| Domain | Peptidase_C15 | 1.11e-04 | 2 | 197 | 2 | IPR000816 | |
| Domain | Peptidase_C15-like | 1.11e-04 | 2 | 197 | 2 | IPR016125 | |
| Domain | Peptidase_C15 | 1.11e-04 | 2 | 197 | 2 | PF01470 | |
| Domain | PYRASE_CYS | 1.11e-04 | 2 | 197 | 2 | PS01334 | |
| Domain | PYRASE_GLU | 1.11e-04 | 2 | 197 | 2 | PS01333 | |
| Domain | Dopey_N | 1.11e-04 | 2 | 197 | 2 | PF04118 | |
| Domain | TATA-bd_TIP120 | 1.11e-04 | 2 | 197 | 2 | IPR013932 | |
| Domain | - | 1.11e-04 | 2 | 197 | 2 | 3.40.630.20 | |
| Domain | Dopey_N | 1.11e-04 | 2 | 197 | 2 | IPR007249 | |
| Domain | TIP120 | 1.11e-04 | 2 | 197 | 2 | PF08623 | |
| Domain | ATM/Tel1 | 1.11e-04 | 2 | 197 | 2 | IPR015519 | |
| Domain | Cullin | 1.31e-04 | 10 | 197 | 3 | PF00888 | |
| Domain | CULLIN_2 | 1.31e-04 | 10 | 197 | 3 | PS50069 | |
| Domain | Cullin_N | 1.31e-04 | 10 | 197 | 3 | IPR001373 | |
| Domain | CULLIN_1 | 1.31e-04 | 10 | 197 | 3 | PS01256 | |
| Domain | DAGKc | 3.86e-04 | 14 | 197 | 3 | SM00046 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.79e-04 | 15 | 197 | 3 | IPR002553 | |
| Domain | Diacylglycerol_kinase_cat_dom | 4.79e-04 | 15 | 197 | 3 | IPR001206 | |
| Domain | DAGK | 4.79e-04 | 15 | 197 | 3 | PS50146 | |
| Domain | PI3/4_kinase_CS | 4.79e-04 | 15 | 197 | 3 | IPR018936 | |
| Domain | Adaptin_N | 4.79e-04 | 15 | 197 | 3 | PF01602 | |
| Domain | DAGK_cat | 4.79e-04 | 15 | 197 | 3 | PF00781 | |
| Domain | - | 5.85e-04 | 16 | 197 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.85e-04 | 16 | 197 | 3 | SM00146 | |
| Domain | NIPSNAP | 6.55e-04 | 4 | 197 | 2 | IPR012577 | |
| Domain | NIPSNAP | 6.55e-04 | 4 | 197 | 2 | PF07978 | |
| Domain | NAD/diacylglycerol_kinase | 7.05e-04 | 17 | 197 | 3 | IPR016064 | |
| Domain | PI3_PI4_kinase | 8.39e-04 | 18 | 197 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 8.39e-04 | 18 | 197 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.39e-04 | 18 | 197 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 8.39e-04 | 18 | 197 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 8.39e-04 | 18 | 197 | 3 | PS50290 | |
| Domain | FATC | 1.08e-03 | 5 | 197 | 2 | PF02260 | |
| Domain | - | 1.61e-03 | 6 | 197 | 2 | 3.90.1290.10 | |
| Domain | FAT | 1.61e-03 | 6 | 197 | 2 | PS51189 | |
| Domain | FATC | 1.61e-03 | 6 | 197 | 2 | PS51190 | |
| Domain | FATC_dom | 1.61e-03 | 6 | 197 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.61e-03 | 6 | 197 | 2 | IPR014009 | |
| Domain | FATC | 1.61e-03 | 6 | 197 | 2 | SM01343 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 3.35e-06 | 11 | 145 | 4 | M27372 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPHK2 SPEG PIEZO1 INTS1 CUL9 EXTL3 BIRC6 SLC52A3 PCNX2 EHBP1L1 LMAN2L DST SPHK1 PI4KA NLRC5 AP1G2 PLEC HERC1 BRAT1 SCARA3 DYNC1H1 KIAA0930 LAMB3 FRYL BTAF1 HUWE1 DHX30 CCDC88C MROH1 HPS6 LRP4 PKN1 MAPKBP1 PCNT | 1.86e-15 | 1105 | 202 | 34 | 35748872 |
| Pubmed | RPL28 CAND1 ERCC6L ERAP1 INTS1 DHRS13 MCM7 PSMD11 BIRC6 NUP205 EHBP1L1 INTS2 PI4KA RECQL4 ATP11A BRAT1 DYNC1H1 RUSF1 IPO5 DIP2B CARMIL2 COPB1 IARS1 MYO18A HUWE1 ECH1 LRPPRC NOP14 PELP1 EIF2S1 HPS6 ATP2B1 PCNT | 5.53e-14 | 1168 | 202 | 33 | 19946888 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL28 WAPL CAND1 ACAT2 PSMD5 MCM7 PSMD11 BIRC6 NUP205 CYFIP1 DST PI4KA RECQL4 DIAPH1 AP1G2 PLEC TARS1 DYNC1H1 VCP PARP12 COPB1 ARHGAP23 COPG1 IARS1 DGKD HUWE1 RFC5 ECH1 DHX30 LRPPRC NOP14 EIF2S1 ATP2B1 | 3.06e-12 | 1353 | 202 | 33 | 29467282 |
| Pubmed | CAND1 ERCC6L MCM7 PSMD11 NUP205 CYFIP1 TELO2 DIAPH1 PLEC TARS1 DYNC1H1 VCP CUL4B IPO5 COPB1 COPG1 IARS1 USP24 HUWE1 DHX30 LRPPRC PELP1 EIF2S1 | 4.03e-12 | 638 | 202 | 23 | 33239621 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | WAPL CAND1 CAND2 ERCC6L EARS2 USE1 PSMD11 NUP205 NAA25 TELO2 PI4KA BRAT1 TARS1 DYNC1H1 VCP COPB1 COPG1 FKRP IARS1 USP24 DNAH2 RANBP6 BTAF1 HUWE1 LRPPRC CCN1 EIF2S1 | 9.76e-12 | 942 | 202 | 27 | 31073040 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL28 PDE3A CAND1 ACAT2 PSMD5 MCM7 PSMD11 BIRC6 NUP205 EHBP1L1 CYFIP1 TELO2 DIAPH1 PLEC HERC1 BRAT1 PRPF39 TARS1 DYNC1H1 GOT1 VCP CUL4B CUL4A IPO5 COPB1 COPG1 IARS1 USP24 RANBP6 FRYL HUWE1 AKT1S1 EIF2S1 | 2.11e-11 | 1455 | 202 | 33 | 22863883 |
| Pubmed | MYO1D INTS1 CUL9 BIRC6 NUP205 DST PLEC DYNC1H1 VCP CUL4B IPO5 COPB1 COPG1 USP24 FRYL HUWE1 DHX30 LRPPRC NOP14 PELP1 ATM PCNT | 4.47e-11 | 653 | 202 | 22 | 22586326 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | CAND1 MYO1D MCM7 PSMD11 CYFIP1 TELO2 FAM83D BRAT1 DYNC1H1 PARP12 MYO18A HUWE1 EIF2S1 KIAA1217 HPS6 | 5.19e-11 | 264 | 202 | 15 | 32814769 |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | PSMD11 CYFIP1 PLEC DYNC1H1 CUL4A IPO5 ANK1 COPB1 COPG1 HUWE1 RFC5 DHX30 THBS1 | 6.12e-11 | 182 | 202 | 13 | 31067453 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL28 CAND1 MYO1D INTS1 MCM7 PSMD11 NUP205 DST PI4KA PLEC TARS1 DYNC1H1 VCP KIF22 IPO5 COPB1 IARS1 BTAF1 HUWE1 RFC5 DHX30 LRPPRC PELP1 CCN1 EIF2S1 ATP2B1 PCNT | 6.38e-11 | 1024 | 202 | 27 | 24711643 |
| Pubmed | SMG1 CAND1 CAND2 CENPB USE1 MCM7 PSMD11 EXTL3 NUP205 DST TELO2 IFI44L DYNC1H1 VCP PARP12 IPO5 TMED1 COPB1 COPG1 RANBP6 BTAF1 HUWE1 RFC5 ARG2 LRPPRC PELP1 EIF2S1 SIPA1L1 LRP4 ATM STX16 ATP2B1 | 7.41e-11 | 1440 | 202 | 32 | 30833792 | |
| Pubmed | KDM5B WAPL CAND1 CUL9 PSMD5 EXTL3 FN3K NAA25 DST EHMT2 PLEC TARS1 RECK DYNC1H1 VCP DOP1B IPO5 COPB1 HUWE1 CPNE5 DHX30 ARG2 THBS1 CCN1 SIPA1L1 LRP4 ATM CCDC24 PCNT | 4.47e-10 | 1285 | 202 | 29 | 35914814 | |
| Pubmed | PDE3A MCM7 PSMD11 CYFIP1 SLMAP TARS1 DYNC1H1 KIF22 CUL4A IPO5 COPB1 IARS1 HUWE1 EIF2S1 SIPA1L1 ATP2B1 | 1.92e-09 | 399 | 202 | 16 | 37536630 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | INTS1 PSMD11 EXTL3 NUP205 LMAN2L INTS2 HERC1 PRPF39 RUSF1 TMPPE KIAA0930 PDPR FKRP FASTKD1 RANBP6 BTAF1 HUWE1 S1PR5 MROH1 HPS6 PKN1 TYW1 ATM TNFRSF1A STX16 | 3.38e-09 | 1061 | 202 | 25 | 33845483 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYO1D MRS2 EARS2 USE1 PSMD11 BIRC6 DST TELO2 EHMT2 PI4KA PDCL3 ANGEL2 SLMAP HERC1 VCP IPO5 DIP2B PDPR FASTKD1 RANBP6 HUWE1 RFC5 ECH1 TSFM DHX30 ARG2 LRPPRC NOP14 KIAA1217 PCNT | 3.40e-09 | 1496 | 202 | 30 | 32877691 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL28 TMPRSS15 WAPL CAND1 INTS1 MCM7 STAT5A NUP205 DIAPH1 PLEC PRPF39 DYNC1H1 KIF22 CUL4A ANK1 COPB1 COPG1 IARS1 USP24 HUWE1 RFC5 ECH1 TSFM DHX30 LRPPRC NOP14 MEIOC EIF2S1 | 3.48e-09 | 1318 | 202 | 28 | 30463901 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPL28 CAND1 CAND2 EARS2 INTS1 MCM7 PSMD11 BIRC6 NUP205 CYFIP1 TELO2 BRAT1 PRPF39 TARS1 DYNC1H1 VCP IPO5 DDX12P COPB1 COPG1 IARS1 BTAF1 HUWE1 RFC5 DHX30 LRPPRC EIF2S1 | 5.41e-09 | 1257 | 202 | 27 | 37317656 |
| Pubmed | RPL28 CAND1 PSMD5 MCM7 PSMD11 NUP205 PI4KA DIAPH1 PLEC TARS1 DYNC1H1 VCP IPO5 COPB1 COPG1 IARS1 DHX30 LRPPRC PELP1 EIF2S1 | 7.02e-09 | 707 | 202 | 20 | 19738201 | |
| Pubmed | 9.81e-09 | 72 | 202 | 8 | 36376293 | ||
| Pubmed | PDE3A CAND1 CENPB EARS2 ERAP1 PSMD11 BIRC6 CYFIP1 LMAN2L DST DIAPH1 ATP11A BRAT1 SCARA3 DYNC1H1 VCP KIF22 IPO5 COPG1 IARS1 USP24 NIPSNAP3A TSFM DHX30 LRPPRC PELP1 CCN1 | 1.04e-08 | 1297 | 202 | 27 | 33545068 | |
| Pubmed | KDM5B CAND1 INTS1 MCM7 BIRC6 NUP205 LMAN2L INTS2 EHMT2 ANGEL2 CUL4B IPO5 TRIM71 HUWE1 CCDC141 PELP1 | 1.87e-08 | 469 | 202 | 16 | 27634302 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B ERCC6L MAP3K3 DST PI4KA PLEC DOP1B CUL4A DIP2B KIAA0930 CARMIL2 BRSK2 FRYL AKT1S1 CCDC88C LRPPRC KIAA1217 SIPA1L1 RAB11FIP5 ATP2B1 DOP1A | 3.71e-08 | 861 | 202 | 21 | 36931259 |
| Pubmed | RPL28 MYO1D NUP205 CYFIP1 PLEC DYNC1H1 VCP COPB1 COPG1 IARS1 MYO18A LRPPRC ATP2B1 | 4.21e-08 | 312 | 202 | 13 | 37120454 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RPL28 MYO1D ERAP1 MCM7 PSMD11 PLEC PRPF39 DYNC1H1 VCP COPB1 COPG1 IARS1 MYO18A LAMB3 HUWE1 RFC5 LRPPRC ATP2B1 | 5.29e-08 | 647 | 202 | 18 | 26618866 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | WAPL CAND1 ERCC6L INTS1 PSMD11 DIAPH1 PLEC DYNC1H1 IPO5 COPB1 COPG1 USP24 BTAF1 HUWE1 RFC5 ATM PCNT | 6.31e-08 | 582 | 202 | 17 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL28 WAPL CAND1 MYO1D MCM7 PSMD11 NUP205 CYFIP1 PI4KA DIAPH1 TARS1 DYNC1H1 IPO5 COPB1 COPG1 IARS1 NIPSNAP3A HUWE1 RFC5 TSFM DHX30 LRPPRC PELP1 EIF2S1 ATM STX16 ATP2B1 | 7.14e-08 | 1425 | 202 | 27 | 30948266 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | INTS1 BIRC6 NUP205 DST TRPM3 PI4KA RECQL4 DYNC1H1 DOP1B ANK1 TBC1D30 COPG1 IARS1 DNAH2 LAMB3 GRIK5 HUWE1 ATM LONRF2 | 7.15e-08 | 736 | 202 | 19 | 29676528 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL28 MYO1D MCM7 NUP205 CYFIP1 DST ANGEL2 SLMAP PLEC TARS1 DYNC1H1 IARS1 MYO18A LAMA3 LAMB3 RFC5 DHX30 LRPPRC THBS1 NOP14 PELP1 CCN1 EIF2S1 KIAA1217 SIPA1L1 | 9.17e-08 | 1257 | 202 | 25 | 36526897 |
| Pubmed | SMG1 WAPL CAND1 CAND2 EARS2 PIEZO1 NUP205 NRXN3 DST INTS2 TELO2 AP5Z1 SLMAP PDPR LRP4 RAB11FIP5 | 9.76e-08 | 529 | 202 | 16 | 14621295 | |
| Pubmed | 1.36e-07 | 9 | 202 | 4 | 12482924 | ||
| Pubmed | 1.97e-07 | 191 | 202 | 10 | 33762435 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SMG1 CENPB USE1 BIRC6 EHBP1L1 LMAN2L TELO2 ATP11A HERC1 TMED1 MYO18A DGKD BTAF1 NOP14 LRP4 RAB11FIP5 TYW1 ATP2B1 | 2.52e-07 | 719 | 202 | 18 | 35337019 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL28 CAND1 PSMD5 MCM7 DST DIAPH1 PLEC TARS1 DYNC1H1 VCP IPO5 COPB1 COPG1 IARS1 HUWE1 ECH1 LRPPRC MYO15A STX16 | 2.93e-07 | 807 | 202 | 19 | 30575818 |
| Pubmed | RPL28 CAND1 MYO1D MCM7 PSMD11 CYFIP1 DIAPH1 FAM83D TARS1 DYNC1H1 VCP PARP12 KIF22 CUL4A IPO5 COPB1 IARS1 HUWE1 RFC5 DHX30 LRPPRC CCN1 EIF2S1 SIPA1L1 | 3.06e-07 | 1247 | 202 | 24 | 27684187 | |
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 10811835 | ||
| Pubmed | Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. | 3.53e-07 | 11 | 202 | 4 | 31570706 | |
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 3.53e-07 | 11 | 202 | 4 | 16757171 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 4.58e-07 | 27 | 202 | 5 | 23027611 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.15e-07 | 212 | 202 | 10 | 33853758 | |
| Pubmed | CAND2 MRS2 MCM7 PSMD11 DIAPH1 TARS1 DYNC1H1 VCP CUL4A IARS1 RANBP6 HUWE1 LRPPRC ATP2B1 | 5.43e-07 | 457 | 202 | 14 | 22190034 | |
| Pubmed | RPL28 CAND2 MRS2 EARS2 USE1 PIEZO1 DHRS13 BBS2 TELO2 EHMT2 PI4KA SLMAP TARS1 VCP PDPR MYO18A ECH1 DHX30 LRPPRC NOP14 EIF2S1 RAB11FIP5 TYW1 ATM ATP2B1 PCNT | 5.90e-07 | 1487 | 202 | 26 | 33957083 | |
| Pubmed | USE1 MCM7 DST AP5Z1 PLEC DYNC1H1 VCP IPO5 ANK1 IARS1 HUWE1 THBS1 | 6.43e-07 | 332 | 202 | 12 | 37433992 | |
| Pubmed | RPL28 WAPL CAND1 MCM7 PSMD11 DST PI4KA DIAPH1 TARS1 DYNC1H1 COPB1 IARS1 DHX30 LRPPRC EIF2S1 | 6.92e-07 | 538 | 202 | 15 | 28524877 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | WAPL CENPB CUL9 NUP205 PI4KA AP5Z1 RECQL4 SLMAP PRPF39 DYNC1H1 KIF22 TMED1 COPG1 IARS1 BTAF1 HUWE1 NOP14 PELP1 ATP2B1 | 7.23e-07 | 857 | 202 | 19 | 25609649 |
| Pubmed | SPHK2 CAND1 MAP3K3 FN3K GHSR EHMT2 SPHK1 CUL4A GRIK5 ATM MAPK3 | 7.34e-07 | 276 | 202 | 11 | 28319085 | |
| Pubmed | 8.17e-07 | 172 | 202 | 9 | 27375898 | ||
| Pubmed | 8.86e-07 | 225 | 202 | 10 | 12168954 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CAND2 PSMD5 MCM7 BIRC6 NUP205 CYFIP1 EHMT2 PRPF39 DYNC1H1 PDPR COPB1 COPG1 GRIK5 HUWE1 RFC5 DHX30 EIF2S1 | 9.00e-07 | 704 | 202 | 17 | 29955894 |
| Pubmed | RPL28 CAND1 MYO1D CYFIP1 DST PI4KA PLEC TARS1 DYNC1H1 GOT1 VCP IPO5 CARMIL2 COPB1 ARHGAP23 IARS1 BRSK2 MYO18A DHX30 LRPPRC EIF2S1 KIAA1217 SIPA1L1 MAPK3 ATP2B1 | 1.01e-06 | 1431 | 202 | 25 | 37142655 | |
| Pubmed | CAND1 ACAT2 MCM7 PSMD11 AP5Z1 BRAT1 TARS1 DYNC1H1 VCP CUL4B IPO5 COPG1 IARS1 USP24 HUWE1 ARG2 LRPPRC MAPK3 ATP2B1 | 1.03e-06 | 878 | 202 | 19 | 37223481 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL28 CAND1 CAND2 ACAT2 MCM7 PSMD11 CYFIP1 DST DIAPH1 PLEC TARS1 DYNC1H1 GOT1 VCP IPO5 COPB1 COPG1 IARS1 MYO18A HUWE1 LRPPRC EIF2S1 | 1.08e-06 | 1149 | 202 | 22 | 35446349 |
| Pubmed | WAPL MCM7 CYFIP1 TELO2 AP5Z1 DIAPH1 DYNC1H1 CUL4B CUL4A IPO5 COPB1 COPG1 RFC5 LRPPRC PELP1 | 1.14e-06 | 560 | 202 | 15 | 35241646 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | RPL28 CAND2 INTS1 PSMD11 NUP205 PTPN7 INTS2 SLMAP HERC1 DYNC1H1 DOP1B ECH1 LRPPRC MAPK3 ATP2B1 | 1.51e-06 | 573 | 202 | 15 | 28330616 |
| Pubmed | RPL28 CAND1 PSMD11 BIRC6 INTS2 TELO2 BRAT1 VCP IPO5 TMED1 COPG1 IARS1 RANBP6 BTAF1 HUWE1 LRPPRC | 1.71e-06 | 657 | 202 | 16 | 36180527 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RPL28 MYO1D ERCC6L ACAT2 MCM7 PSMD11 NUP205 NAA25 TELO2 SLMAP HERC1 TARS1 DYNC1H1 VCP KIAA0930 COPG1 IARS1 NTHL1 FRYL RFC5 LRPPRC EIF2S1 CENPH | 1.86e-06 | 1284 | 202 | 23 | 17353931 |
| Pubmed | T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. | 1.91e-06 | 5 | 202 | 3 | 19808259 | |
| Pubmed | 1.94e-06 | 142 | 202 | 8 | 30809309 | ||
| Pubmed | WAPL CAND1 CENPB INTS1 MCM7 NUP205 EHMT2 DIAPH1 PLEC BRAT1 TARS1 VCP CUL4B CUL4A IPO5 RFC5 EIF2S1 CENPH ATM MYO15A | 2.19e-06 | 1014 | 202 | 20 | 32416067 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USE1 INTS1 MCM7 NUP205 NAA25 CYFIP1 LMAN2L INTS2 GLI2 PLEC BRAT1 RUSF1 VCP IPO5 COPB1 IARS1 LAMB3 NOP14 PELP1 RAB11FIP5 STX16 ATP2B1 | 2.27e-06 | 1203 | 202 | 22 | 29180619 |
| Pubmed | 2.51e-06 | 197 | 202 | 9 | 31620119 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL28 CAND1 MCM7 PSMD11 CYFIP1 PLEC DYNC1H1 CUL4B COPB1 IARS1 DNAH2 HKDC1 RFC5 EIF2S1 KIAA1217 ATP2B1 DOP1A PCNT | 2.59e-06 | 847 | 202 | 18 | 35235311 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.65e-06 | 104 | 202 | 7 | 31240132 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | CAND1 MCM7 PSMD11 DYNC1H1 CUL4A IARS1 HKDC1 HUWE1 LRPPRC EIF2S1 | 2.83e-06 | 256 | 202 | 10 | 35777956 |
| Pubmed | CAND1 CAND2 EARS2 PSMD11 TELO2 PI4KA BRAT1 CUL4B CUL4A COPB1 RANBP6 HUWE1 XRCC3 LRPPRC HPS6 | 2.99e-06 | 606 | 202 | 15 | 36538041 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 3.03e-06 | 258 | 202 | 10 | 21081666 | |
| Pubmed | CAND1 MCM7 PSMD11 NUP205 LMAN2L TARS1 DYNC1H1 VCP HUWE1 DHX30 LRPPRC PELP1 ATP2B1 | 3.61e-06 | 463 | 202 | 13 | 34901782 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 24903384 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 20301304 | ||
| Pubmed | 3.92e-06 | 156 | 202 | 8 | 22952844 | ||
| Pubmed | RPL28 CAND1 MCM7 PSMD11 PLEC TARS1 DYNC1H1 VCP CUL4B COPB1 IARS1 LRPPRC | 4.10e-06 | 397 | 202 | 12 | 21319273 | |
| Pubmed | MYO1D PSMD11 CYFIP1 VCP COPB1 COPG1 IARS1 LAMB3 TRIM71 HUWE1 DHX30 LRPPRC EIF2S1 | 4.15e-06 | 469 | 202 | 13 | 37314180 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RPL28 NIPSNAP3B ERAP1 SPEG NAB2 INTS1 MCM7 LMAN2L PLEC VCP PARP12 IPO5 TMED1 TMEM53 PDPR COPB1 ARHGAP23 COPG1 FASTKD1 HKDC1 NIPSNAP3A LRPPRC RAB11FIP5 ATP2B1 | 4.29e-06 | 1451 | 202 | 24 | 30550785 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SMG1 RPL28 MYO1D MCM7 PLEC DYNC1H1 VCP COPG1 MYO18A RFC5 DHX30 LRPPRC EIF2S1 KIAA1217 SIPA1L1 | 4.42e-06 | 626 | 202 | 15 | 33644029 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RPL28 CAND1 CAND2 PSMD11 FN3K NUP205 PTPN7 CYFIP1 TELO2 VCP IPO5 DIP2B TMED1 COPG1 RANBP6 HUWE1 LRPPRC MAPK3 ATP2B1 | 4.66e-06 | 974 | 202 | 19 | 28675297 |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 4.95e-06 | 161 | 202 | 8 | 32572027 | |
| Pubmed | MRS2 PSMD5 PSMD11 DST SLMAP PLEC HERC1 VCP HAP1 ADCK5 USP24 HUWE1 PCNT | 5.45e-06 | 481 | 202 | 13 | 28190767 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CAND1 BIRC6 DIAPH1 PLEC DYNC1H1 IPO5 DIP2B COPB1 IARS1 USP24 HUWE1 | 6.12e-06 | 344 | 202 | 11 | 30333137 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | CAND1 NUP205 CYFIP1 DIAPH1 DYNC1H1 COPB1 COPG1 IARS1 USP24 HUWE1 LRPPRC | 6.12e-06 | 344 | 202 | 11 | 36282215 |
| Pubmed | RPL28 CYFIP1 DIAPH1 PLEC DYNC1H1 VCP COPG1 MYO18A LAMA3 LAMB3 THBS1 CCN1 EIF2S1 | 6.37e-06 | 488 | 202 | 13 | 31324722 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 6.41e-06 | 221 | 202 | 9 | 29991511 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 6.50e-06 | 119 | 202 | 7 | 35776542 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 10637308 | ||
| Pubmed | 6.86e-06 | 120 | 202 | 7 | 27320910 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | CAND1 MCM7 PSMD11 BIRC6 NUP205 TELO2 PI4KA TARS1 DYNC1H1 VCP COPB1 COPG1 IARS1 HUWE1 | 7.17e-06 | 571 | 202 | 14 | 37167062 |
| Pubmed | RPL28 CAND1 PSMD11 DIAPH1 PLEC PRPF39 TARS1 VCP IPO5 COPB1 COPG1 IARS1 EIF2S1 | 7.25e-06 | 494 | 202 | 13 | 26831064 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | CAND1 FBXL8 PSMD11 DIAPH1 VCP CUL4B CUL4A IPO5 COPB1 COPG1 IARS1 HUWE1 LRPPRC | 7.41e-06 | 495 | 202 | 13 | 28581483 |
| Pubmed | 7.98e-06 | 288 | 202 | 10 | 23383273 | ||
| Pubmed | Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway. | 8.97e-06 | 23 | 202 | 4 | 22038470 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 9.13e-06 | 175 | 202 | 8 | 25756610 | |
| Pubmed | EHBP1L1 DST EHMT2 SLMAP PLEC DYNC1H1 IARS1 BTAF1 KIAA1217 MMRN2 PCNT | 9.38e-06 | 360 | 202 | 11 | 33111431 | |
| Pubmed | SMG1 RPL28 PSMD11 DST DIAPH1 PLEC HERC1 DYNC1H1 TMED1 RANBP6 HUWE1 DHX30 PELP1 STX16 | 1.06e-05 | 591 | 202 | 14 | 15231748 | |
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 20810650 | ||
| Pubmed | CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. | 1.06e-05 | 8 | 202 | 3 | 12504026 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL28 MCM7 DST PLEC DYNC1H1 VCP KIF22 CUL4A IPO5 COPB1 COPG1 IARS1 NTHL1 MYO18A DHX30 LRPPRC EIF2S1 RAB11FIP5 | 1.22e-05 | 949 | 202 | 18 | 36574265 |
| Pubmed | A chemical tool for blue light-inducible proximity photo-crosslinking in live cells. | 1.27e-05 | 25 | 202 | 4 | 35211260 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TMPRSS15 CAND2 EARS2 GPR152 SLC52A3 KAT2B EHBP1L1 CYFIP1 INTS2 ATP11A HERC1 DOP1B DIP2B COPG1 USP24 FRYL TSFM LRPPRC USHBP1 MYO15A CCDC24 | 1.28e-05 | 1242 | 202 | 21 | 30973865 |
| Pubmed | 1.31e-05 | 52 | 202 | 5 | 9455477 | ||
| Pubmed | ERCC6L EARS2 ERAP1 INTS1 PSMD5 PSMD11 XKR7 EHBP1L1 TRPM3 RUSF1 VCP KIF22 CUL4B FASTKD1 USHBP1 | 1.38e-05 | 689 | 202 | 15 | 36543142 | |
| Pubmed | CAND1 ACAT2 USE1 PSMD11 STAT5A TELO2 VCP IPO5 COPB1 COPG1 HUWE1 RAB11FIP5 | 1.41e-05 | 449 | 202 | 12 | 31732153 | |
| Pubmed | CAND1 CYFIP1 DST EHMT2 PI4KA DIAPH1 DYNC1H1 DIP2B GRIK5 HUWE1 CCDC88C LRPPRC PELP1 KIAA1217 SIPA1L1 PKN1 MAPK3 PCNT | 1.48e-05 | 963 | 202 | 18 | 28671696 | |
| Interaction | FPR1 interactions | EARS2 ERAP1 INTS1 INTS2 TELO2 PI4KA AP5Z1 BRAT1 RUSF1 DOP1B FASTKD1 USP24 BTAF1 ATM | 1.95e-10 | 147 | 197 | 14 | int:FPR1 |
| Interaction | NPTN interactions | SMG1 CAND2 EARS2 INTS1 TELO2 PI4KA AP5Z1 BRAT1 DOP1B FASTKD1 USP24 BTAF1 HUWE1 XRCC3 MROH1 ATM ATP2B1 DOP1A | 2.90e-10 | 278 | 197 | 18 | int:NPTN |
| Interaction | P2RY8 interactions | ERAP1 INTS1 EXTL3 NUP205 INTS2 TELO2 PI4KA BRAT1 RUSF1 FASTKD1 BTAF1 MROH1 ATM ATP2B1 | 2.63e-09 | 179 | 197 | 14 | int:P2RY8 |
| Interaction | GPR182 interactions | CAND1 CAND2 EARS2 ERAP1 INTS1 EXTL3 NUP205 TELO2 PI4KA AP5Z1 BRAT1 RUSF1 DOP1B FASTKD1 USP24 BTAF1 LIPE MROH1 TYW1 ATM ATP2B1 | 4.31e-09 | 455 | 197 | 21 | int:GPR182 |
| Interaction | OPALIN interactions | CAND2 ERAP1 INTS1 NUP205 INTS2 TELO2 PI4KA RUSF1 DOP1B FASTKD1 BTAF1 MROH1 ATM ATP2B1 | 1.93e-08 | 209 | 197 | 14 | int:OPALIN |
| Interaction | TOP3B interactions | SPHK2 MYO1D SPEG PIEZO1 INTS1 CUL9 EXTL3 BIRC6 SLC52A3 PCNX2 EHBP1L1 LMAN2L DST SPHK1 PI4KA NLRC5 AP1G2 PLEC HERC1 BRAT1 SCARA3 DYNC1H1 IPO5 KIAA0930 IARS1 LAMB3 FRYL BTAF1 HUWE1 DHX30 CCDC88C MROH1 PELP1 HPS6 LRP4 PKN1 MAPKBP1 PCNT | 2.83e-08 | 1470 | 197 | 38 | int:TOP3B |
| Interaction | SIRT7 interactions | MYO1D INTS1 CUL9 MCM7 BIRC6 NUP205 KAT2B DST PLEC DYNC1H1 VCP CUL4B CUL4A IPO5 COPB1 COPG1 USP24 FRYL HUWE1 DHX30 LRPPRC NOP14 PELP1 ATM PCNT | 7.64e-08 | 744 | 197 | 25 | int:SIRT7 |
| Interaction | CCDC8 interactions | RPL28 CAND1 MYO1D INTS1 CUL9 MCM7 NUP205 DST PI4KA RECQL4 PLEC DYNC1H1 VCP COPB1 IARS1 BTAF1 HUWE1 RFC5 DHX30 LRPPRC EIF2S1 ATP2B1 PCNT | 1.25e-07 | 656 | 197 | 23 | int:CCDC8 |
| Interaction | GPR17 interactions | WAPL CAND2 ERAP1 INTS1 NAA25 INTS2 BRAT1 TMPPE SLC2A8 FASTKD1 USP24 RANBP6 BTAF1 ATM DOP1A | 1.32e-07 | 283 | 197 | 15 | int:GPR17 |
| Interaction | NPY2R interactions | 2.56e-07 | 66 | 197 | 8 | int:NPY2R | |
| Interaction | GPR55 interactions | 2.88e-07 | 67 | 197 | 8 | int:GPR55 | |
| Interaction | MFSD4A interactions | CAND1 EARS2 ERAP1 INTS1 DHRS13 TELO2 PI4KA BRAT1 RUSF1 DOP1B FASTKD1 BTAF1 XRCC3 | 3.50e-07 | 225 | 197 | 13 | int:MFSD4A |
| Interaction | LMBR1L interactions | WAPL CAND1 CAND2 ERCC6L EARS2 USE1 PSMD11 NUP205 NAA25 TELO2 PI4KA BRAT1 TARS1 DYNC1H1 VCP COPB1 COPG1 FKRP IARS1 USP24 DNAH2 RANBP6 BTAF1 HUWE1 LRPPRC CCN1 EIF2S1 | 5.78e-07 | 946 | 197 | 27 | int:LMBR1L |
| Interaction | HLA-B interactions | ERAP1 INTS1 NUP205 TELO2 PI4KA TARS1 RUSF1 VCP DOP1B FASTKD1 BTAF1 HUWE1 MROH1 | 6.95e-07 | 239 | 197 | 13 | int:HLA-B |
| Interaction | ITGB3 interactions | CAND1 BIRC6 DIAPH1 PLEC DYNC1H1 IPO5 COPB1 IARS1 HUWE1 THBS1 MAPK3 | 9.40e-07 | 170 | 197 | 11 | int:ITGB3 |
| Interaction | P2RY10 interactions | 9.84e-07 | 106 | 197 | 9 | int:P2RY10 | |
| Interaction | APLNR interactions | CAND1 ERAP1 INTS1 INTS2 TELO2 PI4KA BRAT1 RUSF1 FASTKD1 BTAF1 XRCC3 ATM | 1.18e-06 | 211 | 197 | 12 | int:APLNR |
| Interaction | RANBP6 interactions | 1.45e-06 | 111 | 197 | 9 | int:RANBP6 | |
| Interaction | GPR45 interactions | EARS2 ERAP1 INTS1 NUP205 INTS2 TELO2 PI4KA BRAT1 RUSF1 FASTKD1 BTAF1 XRCC3 MROH1 ATM | 1.60e-06 | 300 | 197 | 14 | int:GPR45 |
| Interaction | F2RL1 interactions | INTS1 TELO2 PI4KA SLMAP BRAT1 RUSF1 TMED1 FASTKD1 BTAF1 TYW1 ATP2B1 | 1.84e-06 | 182 | 197 | 11 | int:F2RL1 |
| Interaction | STIP1 interactions | CAND1 ERCC6L MCM7 PSMD11 NUP205 CYFIP1 TELO2 PI4KA SSH3 RECQL4 DIAPH1 PLEC TARS1 DYNC1H1 VCP CUL4B IPO5 COPB1 COPG1 IARS1 USP24 HUWE1 XRCC3 DHX30 LRPPRC PELP1 EIF2S1 | 1.87e-06 | 1006 | 197 | 27 | int:STIP1 |
| Interaction | AVPR2 interactions | 3.42e-06 | 123 | 197 | 9 | int:AVPR2 | |
| Interaction | CD274 interactions | CAND1 MCM7 INTS2 TELO2 PI4KA BRAT1 CUL4B CUL4A IPO5 COPB1 COPG1 HUWE1 LRPPRC EIF2S1 ATM | 3.72e-06 | 369 | 197 | 15 | int:CD274 |
| Interaction | MLNR interactions | 4.49e-06 | 68 | 197 | 7 | int:MLNR | |
| Interaction | AR interactions | KDM5B WAPL CAND1 MYO1D PSMD5 MCM7 PSMD11 KAT2B CYFIP1 TELO2 EHMT2 GLI2 FAM83D BRAT1 DYNC1H1 VCP PARP12 CUL4B IARS1 MYO18A HUWE1 PELP1 EIF2S1 KIAA1217 HPS6 TNFRSF1A | 4.54e-06 | 992 | 197 | 26 | int:AR |
| Interaction | EED interactions | RPL28 CAND1 CAND2 MYO1D INTS1 PSMD5 MCM7 PSMD11 BIRC6 NUP205 NAA25 CYFIP1 EHMT2 PLEC TARS1 DYNC1H1 VCP CUL4B CUL4A IPO5 COPB1 COPG1 IARS1 MYO18A TRIM71 HUWE1 RFC5 LRPPRC NOP14 EIF2S1 SIPA1L1 PCNT | 1.11e-05 | 1445 | 197 | 32 | int:EED |
| Interaction | CD80 interactions | 1.23e-05 | 79 | 197 | 7 | int:CD80 | |
| Interaction | NEUROG3 interactions | 1.63e-05 | 149 | 197 | 9 | int:NEUROG3 | |
| Interaction | TPTE2 interactions | 1.84e-05 | 84 | 197 | 7 | int:TPTE2 | |
| Interaction | PTPRH interactions | 1.84e-05 | 84 | 197 | 7 | int:PTPRH | |
| Interaction | EPHA1 interactions | SMG1 CAND1 CAND2 MYO1D NUP205 DST DYNC1H1 COPG1 BTAF1 HUWE1 DHX30 | 2.10e-05 | 235 | 197 | 11 | int:EPHA1 |
| Interaction | HTR6 interactions | 2.14e-05 | 58 | 197 | 6 | int:HTR6 | |
| Interaction | PPP2CA interactions | AHI1 INTS1 PSMD11 MAP3K3 STAT5A PTPN7 INTS2 GLI2 RECQL4 SLMAP VCP CUL4A AKT1S1 LRPPRC ATM MAPK3 | 2.34e-05 | 484 | 197 | 16 | int:PPP2CA |
| Interaction | FN1 interactions | RPL28 CAND1 PSMD5 MCM7 PSMD11 STAT5A NUP205 PI4KA DIAPH1 PLEC TARS1 DYNC1H1 VCP IPO5 COPB1 COPG1 IARS1 DHX30 LRPPRC THBS1 PELP1 EIF2S1 | 3.05e-05 | 848 | 197 | 22 | int:FN1 |
| Interaction | GRWD1 interactions | RPL28 CAND1 MCM7 PDCL3 RECQL4 DYNC1H1 VCP CUL4B CUL4A IARS1 HUWE1 RFC5 DHX30 LRPPRC | 3.15e-05 | 390 | 197 | 14 | int:GRWD1 |
| Interaction | PDK3 interactions | 3.20e-05 | 125 | 197 | 8 | int:PDK3 | |
| Interaction | BRCA1 interactions | RPL28 WAPL CAND1 CENPB ERAP1 PSMD11 MAP3K3 STAT5A DST RECQL4 DIAPH1 PLEC HERC1 BRAT1 PRPF39 TARS1 DYNC1H1 VCP KIF22 CUL4B IPO5 COPB1 COPG1 IARS1 HUWE1 EIF2S1 ATM MAPK3 | 3.40e-05 | 1249 | 197 | 28 | int:BRCA1 |
| Interaction | CDC42 interactions | RPL28 PDE3A USE1 MCM7 PSMD11 NUP205 EHBP1L1 CYFIP1 INTS2 TELO2 PI4KA RECQL4 DIAPH1 ATP11A VCP CUL4A IPO5 COPG1 IARS1 MYO18A FRYL HUWE1 TSFM DHX30 CCN1 RAB11FIP5 TYW1 STX16 ATP2B1 | 3.65e-05 | 1323 | 197 | 29 | int:CDC42 |
| Interaction | FGD5 interactions | 3.82e-05 | 207 | 197 | 10 | int:FGD5 | |
| Interaction | CD70 interactions | 3.83e-05 | 166 | 197 | 9 | int:CD70 | |
| Interaction | PEX3 interactions | 4.84e-05 | 171 | 197 | 9 | int:PEX3 | |
| Interaction | FOXB1 interactions | 5.55e-05 | 135 | 197 | 8 | int:FOXB1 | |
| Interaction | MMS19 interactions | PDE3A DST RECQL4 NLRC5 CUL4A NTHL1 FRYL XRCC3 RFC5 NOP14 EIF2S1 TYW1 | 5.89e-05 | 311 | 197 | 12 | int:MMS19 |
| Interaction | MOB3C interactions | PDE3A MCM7 PSMD11 CYFIP1 TARS1 DYNC1H1 CUL4A IPO5 COPB1 IARS1 HUWE1 EIF2S1 SIPA1L1 | 6.39e-05 | 364 | 197 | 13 | int:MOB3C |
| Interaction | FLT1 interactions | 6.89e-05 | 179 | 197 | 9 | int:FLT1 | |
| Interaction | YWHAH interactions | KDM5B ERCC6L SPEG MAP3K3 CYFIP1 DST PI4KA RECQL4 PLEC HERC1 TARS1 VCP DOP1B DIP2B KIAA0930 CARMIL2 FRYL HUWE1 AKT1S1 CCDC88C KIAA1217 SIPA1L1 RAB11FIP5 DOP1A PCNT | 7.72e-05 | 1102 | 197 | 25 | int:YWHAH |
| Interaction | RHOB interactions | MYO1D NUP205 CYFIP1 PI4KA DIAPH1 ATP11A HERC1 VCP DIP2B BRSK2 MYO18A DGKD DHX30 CCDC88C CCN1 SIPA1L1 LRP4 RAB11FIP5 PKN1 STX16 ATP2B1 | 7.89e-05 | 840 | 197 | 21 | int:RHOB |
| Interaction | LINC01554 interactions | 7.94e-05 | 142 | 197 | 8 | int:LINC01554 | |
| Interaction | UBXN6 interactions | MYO1D ERCC6L NAB2 EHBP1L1 DST TELO2 EHMT2 HERC1 BRAT1 VCP RFC5 THBS1 | 8.96e-05 | 325 | 197 | 12 | int:UBXN6 |
| Interaction | HDAC5 interactions | KDM5B CAND1 MCM7 PSMD11 GLI2 PRPF39 TARS1 VCP COPB1 IARS1 ECH1 LRPPRC THBS1 PKN1 | 9.45e-05 | 432 | 197 | 14 | int:HDAC5 |
| Interaction | RFXANK interactions | 9.64e-05 | 146 | 197 | 8 | int:RFXANK | |
| Interaction | NR2C2 interactions | RPL28 TMPRSS15 WAPL CAND1 INTS1 MCM7 STAT5A NUP205 DIAPH1 PLEC PRPF39 DYNC1H1 KIF22 CUL4B CUL4A ANK1 COPB1 COPG1 IARS1 USP24 HUWE1 RFC5 ECH1 TSFM DHX30 LRPPRC NOP14 MEIOC EIF2S1 | 1.04e-04 | 1403 | 197 | 29 | int:NR2C2 |
| Interaction | CFTR interactions | RPL28 CAND1 MYO1D ERCC6L ERAP1 KIF12 MCM7 PSMD11 CYFIP1 DIAPH1 PLEC PRPF39 DYNC1H1 VCP IPO5 COPB1 COPG1 IARS1 MYO18A LAMA3 LAMB3 HUWE1 RFC5 DHX30 LRPPRC THBS1 CCN1 EIF2S1 RNF139 ATP2B1 | 1.10e-04 | 1480 | 197 | 30 | int:CFTR |
| Interaction | BET1 interactions | USE1 GPR152 NUP205 DST COPG1 IARS1 HUWE1 ECH1 DHX30 USHBP1 EIF2S1 STX16 ATP2B1 | 1.12e-04 | 385 | 197 | 13 | int:BET1 |
| Interaction | HDAC6 interactions | RPL28 MYO1D ERAP1 MCM7 GLI2 RECQL4 SLMAP FAM83D PLEC DYNC1H1 VCP CUL4B COPB1 COPG1 IARS1 MYO18A CCDC141 DHX30 LRPPRC EIF2S1 ATM MAPK3 | 1.16e-04 | 929 | 197 | 22 | int:HDAC6 |
| Interaction | CYLD interactions | RPL28 MCM7 PSMD11 CYFIP1 SPHK1 PLEC DYNC1H1 VCP CUL4A IPO5 ANK1 COPB1 COPG1 IARS1 HUWE1 RFC5 DHX30 THBS1 EIF2S1 MAPK3 TNFRSF1A | 1.25e-04 | 868 | 197 | 21 | int:CYLD |
| Interaction | UBC interactions | MRS2 PSMD5 PSMD11 DST SLMAP PLEC HERC1 VCP HAP1 ADCK5 USP24 HUWE1 TNFRSF1A PCNT | 1.32e-04 | 446 | 197 | 14 | int:UBC |
| Interaction | DNAI2 interactions | 1.33e-04 | 80 | 197 | 6 | int:DNAI2 | |
| Interaction | H2AC4 interactions | CAND1 MCM7 KAT2B RECQL4 KIF22 CUL4B CUL4A IPO5 COPB1 IARS1 RFC5 LRPPRC PELP1 MAPK3 ATP2B1 | 1.43e-04 | 506 | 197 | 15 | int:H2AC4 |
| Interaction | RPL7P32 interactions | 1.43e-04 | 11 | 197 | 3 | int:RPL7P32 | |
| Interaction | HTT interactions | KDM5B ERCC6L ERAP1 MCM7 SLC52A3 KAT2B DST PLEC DYNC1H1 VCP IPO5 ANK1 HAP1 USP24 MYO18A GRIK5 HUWE1 ECH1 DHX30 SIPA1L1 RAB11FIP5 MAPK3 | 1.58e-04 | 949 | 197 | 22 | int:HTT |
| Interaction | COMTD1 interactions | 1.60e-04 | 200 | 197 | 9 | int:COMTD1 | |
| Interaction | PTH2R interactions | 1.71e-04 | 119 | 197 | 7 | int:PTH2R | |
| Interaction | HULC interactions | 1.90e-04 | 161 | 197 | 8 | int:HULC | |
| Interaction | SENP3 interactions | NAB2 MCM7 TRPM3 TELO2 RECQL4 HERC1 TARS1 VCP IPO5 COPG1 PELP1 | 1.93e-04 | 301 | 197 | 11 | int:SENP3 |
| Interaction | MAS1 interactions | 1.99e-04 | 86 | 197 | 6 | int:MAS1 | |
| Interaction | SLC39A4 interactions | 2.06e-04 | 163 | 197 | 8 | int:SLC39A4 | |
| Interaction | CXCR4 interactions | CAND2 ERAP1 PIEZO1 EXTL3 NAA25 AP5Z1 FASTKD1 USP24 BTAF1 ATM | 2.14e-04 | 255 | 197 | 10 | int:CXCR4 |
| Interaction | C9orf72 interactions | RPL28 CAND1 CAND2 EARS2 INTS1 MCM7 PSMD11 BIRC6 NUP205 CYFIP1 TELO2 BRAT1 PRPF39 TARS1 DYNC1H1 VCP IPO5 DDX12P COPB1 COPG1 IARS1 BTAF1 HUWE1 RFC5 DHX30 LRPPRC EIF2S1 | 2.15e-04 | 1319 | 197 | 27 | int:C9orf72 |
| Interaction | KLRB1 interactions | 2.35e-04 | 57 | 197 | 5 | int:KLRB1 | |
| Interaction | INTS4P2 interactions | 2.45e-04 | 13 | 197 | 3 | int:INTS4P2 | |
| Interaction | RPL7AP27 interactions | 2.45e-04 | 13 | 197 | 3 | int:RPL7AP27 | |
| Interaction | GML interactions | 2.55e-04 | 58 | 197 | 5 | int:GML | |
| Interaction | EEF1AKMT3 interactions | ERCC6L NAB2 CUL9 EHBP1L1 TELO2 PI4KA SSH3 AP1G2 HERC1 BRAT1 HUWE1 THBS1 | 2.57e-04 | 364 | 197 | 12 | int:EEF1AKMT3 |
| Interaction | TPTE interactions | 2.80e-04 | 129 | 197 | 7 | int:TPTE | |
| Interaction | PSMA1 interactions | MYO1D NAB2 CUL9 PSMD5 PSMD11 EHMT2 RECQL4 IFI44L VCP CUL4B COPB1 HUWE1 ECH1 LRPPRC | 2.81e-04 | 480 | 197 | 14 | int:PSMA1 |
| Interaction | RHOA interactions | PDE3A ERAP1 USE1 NUP205 CYFIP1 PI4KA SLMAP DIAPH1 ATP11A VCP KIF22 ARHGAP23 MYO18A DGKD FRYL TSFM DHX30 CCDC88C CCN1 IRGC PKN1 TYW1 TNFRSF1A STX16 ATP2B1 | 2.84e-04 | 1199 | 197 | 25 | int:RHOA |
| Interaction | IKBIP interactions | 2.86e-04 | 171 | 197 | 8 | int:IKBIP | |
| Interaction | HTR2C interactions | 2.94e-04 | 130 | 197 | 7 | int:HTR2C | |
| Interaction | PSMD6 interactions | PSMD5 PSMD11 TELO2 RECQL4 DYNC1H1 VCP IPO5 IARS1 HUWE1 LRPPRC EIF2S1 | 3.00e-04 | 317 | 197 | 11 | int:PSMD6 |
| Interaction | GLDC interactions | MYO1D RECQL4 PLEC PRPF39 VCP CUL4A MYO18A DHX30 LRPPRC NOP14 SIPA1L1 | 3.34e-04 | 321 | 197 | 11 | int:GLDC |
| Interaction | INSIG2 interactions | 3.60e-04 | 177 | 197 | 8 | int:INSIG2 | |
| Interaction | MYO18B interactions | 3.84e-04 | 15 | 197 | 3 | int:MYO18B | |
| Interaction | EGLN3 interactions | WAPL CAND1 ERCC6L EARS2 MCM7 PSMD11 BIRC6 NUP205 TELO2 GLI2 PI4KA FAM83D DYNC1H1 VCP IPO5 TMED1 PDPR COPB1 COPG1 USP24 BTAF1 RFC5 LRPPRC HPS6 RAB11FIP5 STX16 | 3.86e-04 | 1296 | 197 | 26 | int:EGLN3 |
| Interaction | DCTN1 interactions | SPHK2 AHI1 MCM7 PSMD11 CYFIP1 DST FAM83D DYNC1H1 CUL4A HAP1 HUWE1 TSFM CCDC88C KIAA1217 | 3.98e-04 | 497 | 197 | 14 | int:DCTN1 |
| Interaction | C9orf78 interactions | WAPL NAB2 MCM7 CYFIP1 TELO2 AP5Z1 DIAPH1 DYNC1H1 CUL4B CUL4A IPO5 COPB1 COPG1 RFC5 LRPPRC PELP1 | 4.08e-04 | 620 | 197 | 16 | int:C9orf78 |
| Interaction | LPAR4 interactions | 4.08e-04 | 36 | 197 | 4 | int:LPAR4 | |
| Interaction | MEX3A interactions | USE1 MCM7 DST AP5Z1 PLEC DYNC1H1 VCP IPO5 ANK1 IARS1 HUWE1 THBS1 | 4.16e-04 | 384 | 197 | 12 | int:MEX3A |
| Interaction | ANKRD55 interactions | 4.22e-04 | 228 | 197 | 9 | int:ANKRD55 | |
| Interaction | GRK5 interactions | 4.34e-04 | 182 | 197 | 8 | int:GRK5 | |
| Interaction | PTPN7 interactions | 4.36e-04 | 65 | 197 | 5 | int:PTPN7 | |
| Interaction | MKS1 interactions | 4.41e-04 | 139 | 197 | 7 | int:MKS1 | |
| Interaction | CD83 interactions | 4.68e-04 | 66 | 197 | 5 | int:CD83 | |
| Interaction | H2AC16 interactions | 4.69e-04 | 16 | 197 | 3 | int:H2AC16 | |
| Interaction | H2AC15 interactions | 4.69e-04 | 16 | 197 | 3 | int:H2AC15 | |
| Interaction | RNF123 interactions | INTS1 BIRC6 NUP205 DST TRPM3 PI4KA RECQL4 DYNC1H1 DOP1B ANK1 TBC1D30 COPG1 IARS1 DNAH2 LAMB3 GRIK5 HUWE1 ATM LONRF2 | 4.80e-04 | 824 | 197 | 19 | int:RNF123 |
| Interaction | RICTOR interactions | RPL28 CAND1 MYO1D NUP205 CYFIP1 TELO2 EHMT2 PLEC DYNC1H1 VCP CUL4B CUL4A COPB1 COPG1 IARS1 MYO18A LRPPRC ATP2B1 | 4.88e-04 | 759 | 197 | 18 | int:RICTOR |
| Interaction | COPS5 interactions | RPL28 CAND1 CAND2 MCM7 MAP3K3 CYFIP1 RECQL4 PRPF39 DYNC1H1 VCP CUL4B CUL4A IARS1 USP24 DNAH2 BRSK2 HUWE1 DHX30 CD93 EIF2S1 ATM MAPK3 RNF139 | 4.98e-04 | 1102 | 197 | 23 | int:COPS5 |
| Interaction | NOS2 interactions | 5.01e-04 | 186 | 197 | 8 | int:NOS2 | |
| Interaction | SLC15A3 interactions | 5.10e-04 | 234 | 197 | 9 | int:SLC15A3 | |
| GeneFamily | Cullins | 1.48e-05 | 8 | 118 | 3 | 1032 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.32e-06 | 180 | 200 | 10 | M8239 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | RPL28 MRS2 MCM7 NUP205 PI4KA AP1G2 KIF22 DOP1B IPO5 KIAA0930 IARS1 FASTKD1 USP24 DGKD HUWE1 LRPPRC ATP2B1 | 5.14e-06 | 612 | 200 | 17 | M4772 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 WAPL CAND2 MRS2 ERAP1 INTS1 CYFIP1 PI4KA PDCL3 ANGEL2 DIAPH1 DYNC1H1 CUL4B CUL4A IPO5 COPB1 IARS1 FASTKD1 BTAF1 ECH1 ARG2 LRPPRC EIF2S1 ATM RNF139 | 6.65e-06 | 1215 | 200 | 25 | M41122 |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RPL28 CAND1 INTS1 PDCL3 ANGEL2 TBC1D30 DGKD FRYL BTAF1 HUWE1 CCDC88C LIPE EIF2S1 ATM | 1.87e-05 | 475 | 200 | 14 | M40979 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | SPHK2 PIEZO1 INTS1 MCM7 EHBP1L1 PI4KA SSH3 NLRC5 AP1G2 IFI44L BRAT1 RUSF1 KIF22 DOP1B KIAA0930 PDPR SLC2A8 MYO18A STX16 PCNT | 2.18e-05 | 905 | 200 | 20 | M40865 |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN | 9.93e-05 | 187 | 200 | 8 | M8589 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | WAPL ERCC6L DHRS13 MCM7 PSMD11 FN3K SPHK1 RECQL4 FAM83D TARS1 VCP ANK1 ARHGAP23 IARS1 NIPSNAP3A XRCC3 RFC5 ECH1 TSFM LRPPRC NOP14 EIF2S1 CENPH | 1.14e-04 | 1271 | 200 | 23 | M39197 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | MYO1D USE1 NAB2 CUL9 MAP3K3 EHMT2 PI4KA RECQL4 TMEM53 COPG1 LAMB3 TSFM DHX30 TNFRSF1A | 1.25e-04 | 567 | 200 | 14 | M16909 |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 1.34e-04 | 146 | 200 | 7 | M41190 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN | 1.37e-04 | 196 | 200 | 8 | M8675 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN | 1.42e-04 | 197 | 200 | 8 | M8338 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP | 1.47e-04 | 198 | 200 | 8 | M6025 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP | 1.47e-04 | 198 | 200 | 8 | M5011 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 1.53e-04 | 199 | 200 | 8 | M316 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP | 1.53e-04 | 199 | 200 | 8 | M6183 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP | 1.53e-04 | 199 | 200 | 8 | M8767 | |
| Coexpression | GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP | 1.53e-04 | 199 | 200 | 8 | M5713 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.58e-04 | 200 | 200 | 8 | M9496 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP | 1.58e-04 | 200 | 200 | 8 | M4617 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_16H_BMDC_UP | 1.58e-04 | 200 | 200 | 8 | M3950 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_DC_UP | 1.58e-04 | 200 | 200 | 8 | M8778 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_UP | 1.58e-04 | 200 | 200 | 8 | M6390 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 1.58e-04 | 200 | 200 | 8 | M6447 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 1.58e-04 | 200 | 200 | 8 | M4313 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.47e-07 | 193 | 201 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 197 | 201 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 197 | 201 | 9 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 198 | 201 | 9 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.34e-07 | 200 | 201 | 9 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-06 | 170 | 201 | 8 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.81e-06 | 193 | 201 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.03e-06 | 195 | 201 | 8 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.52e-06 | 199 | 201 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 199 | 201 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.66e-06 | 200 | 201 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-06 | 161 | 201 | 7 | 2fe77af3b41e6eacb707a64feea18f9991618173 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.67e-06 | 108 | 201 | 6 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 166 | 201 | 7 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 174 | 201 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.56e-05 | 176 | 201 | 7 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 178 | 201 | 7 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 184 | 201 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 184 | 201 | 7 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 185 | 201 | 7 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-05 | 186 | 201 | 7 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 186 | 201 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 187 | 201 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-05 | 188 | 201 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.38e-05 | 188 | 201 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 188 | 201 | 7 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 189 | 201 | 7 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 189 | 201 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 189 | 201 | 7 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 189 | 201 | 7 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.55e-05 | 190 | 201 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.63e-05 | 191 | 201 | 7 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-05 | 129 | 201 | 6 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-05 | 130 | 201 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.81e-05 | 193 | 201 | 7 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 195 | 201 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 195 | 201 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-05 | 133 | 201 | 6 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 197 | 201 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 197 | 201 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 197 | 201 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 198 | 201 | 7 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 198 | 201 | 7 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.42e-05 | 199 | 201 | 7 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Skin-Endothelial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.42e-05 | 199 | 201 | 7 | 6b3ef5d8f87cdfe5401d05f19339ddfcd9cda476 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.42e-05 | 199 | 201 | 7 | 4f02e03c118744fba0dfc5e3ed6dea4041f3d089 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cadm2_(Cadm2_state)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.49e-05 | 82 | 201 | 5 | 01a4d47d9e0dee68a5277ed1534338cec80f75d1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cadm2_(Cadm2_state)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.49e-05 | 82 | 201 | 5 | c1489097c291f413f3cfa5e26f8182ec872328fd | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-CD14+_Monocyte|Leuk-UTI / Disease, condition lineage and cell class | 3.53e-05 | 200 | 201 | 7 | 04d0164b80d424a308ada3fea6bb4a9d6cf686e3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-05 | 200 | 201 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-05 | 83 | 201 | 5 | 7893ce9fbf34c6250dca9c265fe9b2d4cb889ade | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-05 | 144 | 201 | 6 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-05 | 145 | 201 | 6 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-05 | 145 | 201 | 6 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-05 | 157 | 201 | 6 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 164 | 201 | 6 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 165 | 201 | 6 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.05e-04 | 165 | 201 | 6 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 165 | 201 | 6 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 168 | 201 | 6 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 1.19e-04 | 169 | 201 | 6 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.27e-04 | 171 | 201 | 6 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 172 | 201 | 6 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 173 | 201 | 6 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 1.36e-04 | 173 | 201 | 6 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-04 | 173 | 201 | 6 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 173 | 201 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 109 | 201 | 5 | e8e0f2c5f8c9e45f2b4d173569c94275eedfe432 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 175 | 201 | 6 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 175 | 201 | 6 | b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 175 | 201 | 6 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 175 | 201 | 6 | 067c7d89cfdf6ebf70692df64b9b79d752f093dd | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 176 | 201 | 6 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 176 | 201 | 6 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 176 | 201 | 6 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 176 | 201 | 6 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 176 | 201 | 6 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 177 | 201 | 6 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.54e-04 | 112 | 201 | 5 | 518b7ab98b988b23f3d0f0e1f4fe90a7068f9d87 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 179 | 201 | 6 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 179 | 201 | 6 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.63e-04 | 179 | 201 | 6 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.63e-04 | 179 | 201 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 179 | 201 | 6 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 180 | 201 | 6 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 180 | 201 | 6 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 180 | 201 | 6 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 180 | 201 | 6 | 3d54cc767e25d91ed2203d8a03e5bf5e15f21699 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 181 | 201 | 6 | fe2f8b4bd8b09be8ba933529a16e1dca08740dab | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 181 | 201 | 6 | a16079b1c832456b974d9d06dd1a3eda63ac1bce | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 182 | 201 | 6 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.79e-04 | 182 | 201 | 6 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.79e-04 | 182 | 201 | 6 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.84e-04 | 183 | 201 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-04 | 184 | 201 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 185 | 201 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 185 | 201 | 6 | 502361b041a036de024eb5fe378ca09fac9b67ee | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 186 | 201 | 6 | 2f103ce2427f9cf2c1fafb6bd6045c5863a47549 | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | INTS1 EXTL3 PCNX2 PLEC IPO5 TMEM53 LAMA3 DGKD XRCC3 TSFM THBS1 ATM | 1.86e-07 | 198 | 199 | 12 | 7437_DN |
| Drug | D dB | 5.03e-06 | 77 | 199 | 7 | CID006437867 | |
| Drug | PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A | SPEG NAB2 EXTL3 DIAPH1 RECK RUSF1 FHIP2B TBC1D30 USP24 OVGP1 | 7.39e-06 | 191 | 199 | 10 | 7086_DN |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | CUL9 EHBP1L1 SSH3 ANGEL2 DIAPH1 SLC2A8 ASAP3 XRCC3 CCN1 MAPKBP1 | 9.27e-06 | 196 | 199 | 10 | 2775_DN |
| Drug | SC-58125; Down 200; 10uM; SKMEL5; HG-U133A | 9.27e-06 | 196 | 199 | 10 | 507_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | SPHK2 EXTL3 GASK1B PCNX2 GLI2 AP5Z1 TMEM53 SLC2A8 XRCC3 OVGP1 | 9.70e-06 | 197 | 199 | 10 | 3411_UP |
| Drug | SB 203580; Up 200; 1uM; MCF7; HT_HG-U133A | AHI1 ERAP1 NAB2 PCNX2 EHBP1L1 AP5Z1 KIAA0930 ECH1 TSFM RAB11FIP5 | 9.70e-06 | 197 | 199 | 10 | 7061_UP |
| Disease | Gastrointestinal defect and immunodeficiency syndrome | 4.48e-05 | 2 | 198 | 2 | cv:C5234880 | |
| Disease | Junctional epidermolysis bullosa | 1.34e-04 | 3 | 198 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 1.34e-04 | 3 | 198 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 1.34e-04 | 3 | 198 | 2 | 226700 | |
| Disease | Combined immunodeficiency | 1.64e-04 | 41 | 198 | 4 | C0494261 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.89e-04 | 17 | 198 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Hodgkins lymphoma | 2.32e-04 | 82 | 198 | 5 | EFO_0000183 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 2.36e-04 | 45 | 198 | 4 | DOID:3525 (implicated_via_orthology) | |
| Disease | Herlitz Disease | 2.66e-04 | 4 | 198 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 2.66e-04 | 4 | 198 | 2 | C0079297 | |
| Disease | Schizophrenia | AHI1 BLOC1S1 FAM3D CYFIP1 NRXN3 LMAN2L PI4KA IPO5 GRIK5 SLC1A6 THBS1 EIF2S1 ATM MAPK3 TNFRSF1A PCNT | 3.27e-04 | 883 | 198 | 16 | C0036341 |
| Disease | calcium measurement | PDE3A CYP21A2 LYPD2 EHBP1L1 LMAN2L PLEC FHIP2B ASAP3 DNAH2 MYO18A DGKD GRIK5 ATP2B1 | 3.47e-04 | 628 | 198 | 13 | EFO_0004838 |
| Disease | Fibrosis | 3.56e-04 | 50 | 198 | 4 | C0016059 | |
| Disease | Cirrhosis | 3.56e-04 | 50 | 198 | 4 | C1623038 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 4.42e-04 | 5 | 198 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 4.42e-04 | 5 | 198 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 4.42e-04 | 5 | 198 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 6.60e-04 | 6 | 198 | 2 | C0079301 | |
| Disease | hydrocephalus (is_implicated_in) | 6.60e-04 | 6 | 198 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | SPHK2 AHI1 MYO1D PIEZO1 CYP21A2 MCM7 BIRC6 FN3K EHBP1L1 CYFIP1 SPHK1 ATP11A HERC1 CUL4A DIP2B CARMIL2 ANK1 ARHGAP23 ESYT3 KIAA1217 | 7.76e-04 | 1347 | 198 | 20 | EFO_0005192 |
| Disease | fibrinogen measurement | 8.59e-04 | 109 | 198 | 5 | EFO_0004623 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 8.61e-04 | 28 | 198 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 9.20e-04 | 7 | 198 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 9.20e-04 | 7 | 198 | 2 | C0399367 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 9.20e-04 | 7 | 198 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.57e-03 | 74 | 198 | 4 | DOID:3748 (is_marker_for) | |
| Disease | 1,7-dimethylurate measurement | 1.95e-03 | 10 | 198 | 2 | EFO_0021512 | |
| Disease | heart rate variability measurement | 1.95e-03 | 37 | 198 | 3 | EFO_0008003 | |
| Disease | Cataract | 1.95e-03 | 37 | 198 | 3 | C0086543 | |
| Disease | Autistic Disorder | 1.99e-03 | 261 | 198 | 7 | C0004352 | |
| Disease | cancer (implicated_via_orthology) | 2.31e-03 | 268 | 198 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | nevus count, cutaneous melanoma | 3.34e-03 | 91 | 198 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.43e-03 | 45 | 198 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.43e-03 | 45 | 198 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 3.87e-03 | 14 | 198 | 2 | cv:C2931907 | |
| Disease | unipolar depression, bipolar disorder | 4.12e-03 | 156 | 198 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | glutamine measurement | 4.19e-03 | 97 | 198 | 4 | EFO_0009768 | |
| Disease | osteoarthritis, knee | 4.35e-03 | 158 | 198 | 5 | EFO_0004616 | |
| Disease | Down syndrome (implicated_via_orthology) | 4.44e-03 | 15 | 198 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | tumor necrosis factor beta measurement | 4.44e-03 | 15 | 198 | 2 | EFO_0008308 | |
| Disease | obesity (is_marker_for) | 4.84e-03 | 101 | 198 | 4 | DOID:9970 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 5.05e-03 | 16 | 198 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | autism spectrum disorder (is_implicated_in) | 5.05e-03 | 16 | 198 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | platelet crit | AHI1 ERAP1 PIEZO1 CYP21A2 ADCY5 NUP205 PTPN7 NAA25 PLEC DIP2B DGKD THBS1 MEIOC TNFRSF1A | 5.17e-03 | 952 | 198 | 14 | EFO_0007985 |
| Disease | platelet component distribution width | AHI1 CYP21A2 WASF3 ADCY5 FN3K CYFIP1 TRPM3 PLEC HERC1 BRAT1 CUL4A MEIOC | 5.20e-03 | 755 | 198 | 12 | EFO_0007984 |
| Disease | Ischemic stroke, fibrinogen measurement | 6.04e-03 | 55 | 198 | 3 | EFO_0004623, HP_0002140 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 6.35e-03 | 56 | 198 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | drug-Induced dyskinesia, response to levodopa | 6.39e-03 | 18 | 198 | 2 | EFO_0010747, EFO_1000904 | |
| Disease | pancreatic carcinoma | 6.51e-03 | 174 | 198 | 5 | EFO_0002618 | |
| Disease | heart rate response to recovery post exercise | 6.67e-03 | 57 | 198 | 3 | EFO_0009185 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVAAREALADLMLRL | 486 | Q8N6Y0 | |
| EALADLMLRLQLVRR | 491 | Q8N6Y0 | |
| SLISMRLVLRFLQVE | 571 | A0FGR9 | |
| AVLAMLRSLDLEGLR | 771 | Q6PJG6 | |
| DRIAASMRALVLREA | 216 | Q96B36 | |
| LGVRFSRMQSLTLDL | 471 | Q8TDY4 | |
| MSLRGSLSRLLQTRV | 1 | P78540 | |
| LTTDDGVLLRRMALE | 4226 | Q9NR09 | |
| SVMLLLLDIRDRINR | 691 | O60477 | |
| ARSIELDMRTIATAL | 126 | P78537 | |
| DSTLRIMDLRILVAR | 821 | Q8N157 | |
| MVTLVLAIGRSRSLR | 536 | Q6F5E8 | |
| RLRDMRLSITGTLAE | 861 | Q6F5E8 | |
| ASRRGNVIMVRLLLD | 246 | P16157 | |
| MSSRIARALALVVTL | 1 | O00622 | |
| LAQLLRREAALTARM | 76 | Q9NPY3 | |
| LTMHELSLVRVQRRL | 191 | Q8NCL9 | |
| TIMDIRSAAGLRVLA | 296 | O75843 | |
| QLLLEAMLEISSERR | 871 | A6NC57 | |
| RMFHIRAVILRALSL | 6 | P20036 | |
| MIRILSAALHVVLRR | 266 | Q5JWR5 | |
| IRMLLTRGADVTLTD | 801 | Q96KQ7 | |
| FEVALRLETLAMRLT | 541 | Q3MIX3 | |
| RLETLAMRLTALLAR | 546 | Q3MIX3 | |
| AIRTRATELLTLLKM | 746 | O43299 | |
| LRTVSRLVEREAGLM | 791 | O43299 | |
| RMRAAVLSGVLLSAL | 346 | O95622 | |
| RRGDIKLTQLAMLLA | 316 | Q5VTE6 | |
| LRDMPLLSCLESLRV | 156 | O60610 | |
| GRMVERSLRSELAAL | 1146 | Q7L2E3 | |
| LAELRALMELRSTDA | 31 | P20020 | |
| LVVDMALPSSRLLRS | 91 | P0C854 | |
| MLVLRSALTRALASR | 1 | Q9UFN0 | |
| DRLLVRIMETSPTLL | 631 | Q9BXF6 | |
| MATVRASLRGALLLL | 1 | O95980 | |
| RRGSNVALMLDVRSL | 41 | P35236 | |
| IGRMLALALLDRIVS | 1491 | Q92621 | |
| VMAGSLLLDKRLRSE | 716 | Q7L576 | |
| LDRALLESMPSVRLL | 161 | Q9HBL6 | |
| MRVSGVLRLLALIFA | 1 | Q96BQ1 | |
| RALDILLARDRMLAQ | 426 | Q2Q1W2 | |
| LMTVLSRLADVRIQG | 1606 | Q16787 | |
| DTLMRILVIGLSREL | 651 | Q8N201 | |
| LRMIRSEVLRLVDAA | 1221 | Q8N201 | |
| LLRSVFTVMRRQLLE | 311 | Q92831 | |
| RLELPSSIELRAMLA | 3191 | Q9UKN7 | |
| MRDNTLLLRRVELFS | 331 | Q15742 | |
| TALRELRVILMEKSL | 441 | Q9H8L6 | |
| LIDRETMFRLLSAQL | 1766 | Q03001 | |
| NIEGMILLSELSRRR | 41 | P05198 | |
| LEALMELLQTGLSRR | 201 | Q96FN5 | |
| RILSAATQTLLRRDM | 276 | Q9Y3R5 | |
| ILILSALRQMLRAAD | 416 | Q53G44 | |
| RMTVLLITNDVLARG | 611 | P98073 | |
| ESLGLTDIRTLVRLM | 3211 | Q15751 | |
| MLRAIAEERGRLSLR | 1 | Q6ICG6 | |
| LLRGMIEVDAARRLT | 246 | Q8IWQ3 | |
| EALSRSMVLHLRRLI | 186 | Q9P219 | |
| ELKRSAMRAVAALLT | 1171 | Q86VP6 | |
| KLTRSALLLGIRDSM | 121 | P08686 | |
| MSLLRSLRVFLVART | 1 | P43897 | |
| SVSERMLRSQLLLLA | 721 | Q9NZ08 | |
| AATMLQVFDLRRILI | 1516 | A6NKB5 | |
| RSLFSVLVRVIGDLM | 656 | Q86V87 | |
| GRRLSGELISMRDLT | 361 | Q9HB15 | |
| ILRSVMATASREERL | 221 | Q9H344 | |
| DPAMLERLLSLDRLL | 436 | Q14807 | |
| LLRTQLRGSRLLDAM | 1091 | Q92614 | |
| LSSLLRRMPELETLE | 336 | Q8NCN5 | |
| IEDVLLSSVRRSVLM | 216 | Q9H2J4 | |
| ASLLGRALRVIIQEM | 156 | A6NFU8 | |
| LGRALRAIIEEMLDL | 181 | Q9NXJ5 | |
| LRLRLGVLMIALTSA | 206 | Q14432 | |
| RVLQDLVMDILRVLS | 316 | P53618 | |
| MAAGIVASRRLRDLL | 1 | Q13011 | |
| SKELTLGNLLRMRLA | 321 | Q9H4H8 | |
| LGNLLRMRLARLSST | 326 | Q9H4H8 | |
| GMSRTDLIELLARLT | 571 | O94915 | |
| EEITGTDALLRRMLL | 731 | Q9H0H0 | |
| MLVLRSGLTKALASR | 1 | Q9BS92 | |
| RLELSRLARIADTKM | 416 | Q9Y4C0 | |
| RDVSLSSLRMLIVTD | 626 | Q9P265 | |
| RRFELLSRELRAMLA | 1436 | Q8N3D4 | |
| LLADRSMELKNSLRL | 416 | Q9HD23 | |
| MKRRTLLLSLLATEI | 1486 | P42356 | |
| LMASADLRTLLRSVL | 296 | Q8TDT2 | |
| ALMRLDLSVRRTGRI | 86 | P42704 | |
| RCLSARDGSRMLLLL | 16 | Q9H0V9 | |
| MSLRTRLALLDAPER | 911 | P10070 | |
| SSLTLDDMRRLIDLG | 931 | Q9UGL1 | |
| IGIRDILRASTLEAM | 101 | P27361 | |
| ILGMTSLKERLLAIR | 716 | Q1L5Z9 | |
| EEARQMAAVLLRRLL | 56 | O00410 | |
| LRAMERVLSSRASEL | 66 | Q8NDA8 | |
| RSLLLGRSMEEQLLV | 436 | P78316 | |
| ATMELAVAVLRDLLR | 146 | Q8IZL8 | |
| MPTSTILRLLAELVR | 2066 | Q7Z6Z7 | |
| ALQLMLARSRFLEER | 861 | O95613 | |
| EAMRQRLLSAARLLT | 2976 | O95613 | |
| VLGLAMVRLRRVSLE | 451 | Q86UA1 | |
| TILMAKERLEALRTA | 16 | Q6NXR0 | |
| RMLQAREADLIFLLS | 801 | Q86WI3 | |
| MRGTRLALLALVLAA | 1 | Q6UXB3 | |
| RLSTALARLRMVDVV | 611 | P33993 | |
| MLLRLRSVRLLSGSK | 236 | P41143 | |
| LRRRLRMGLSADALE | 26 | Q9H0J9 | |
| TILILVMRRVAGDEL | 366 | Q9ULW2 | |
| IRRMRLLADSAVAGL | 221 | Q6UWH4 | |
| ADIRRKLLMLIDSST | 921 | Q13315 | |
| LDTRMAAESRRVLLL | 281 | P07199 | |
| IRSLLVGAEDARLMR | 621 | Q9BXC9 | |
| LVSMLERRTELLRLT | 116 | Q6ZP82 | |
| MAVSRLDRLFILLDT | 1 | O14981 | |
| SEDRMTLLLRLRAQT | 36 | Q9H3R5 | |
| NLLTMLVVSRFRELR | 61 | Q92847 | |
| SMLARLLRKTIGALN | 511 | Q5T197 | |
| RRAAIELLMVLAGRA | 86 | Q96CD0 | |
| LLRSLSDSDLLAMRR | 496 | O43909 | |
| RSLLRSLLGMLSDLQ | 211 | Q13619 | |
| TLAEELRTSLRRMIS | 486 | P54257 | |
| VFLESLVTNMLRLRA | 6 | Q53R41 | |
| RENLLRLSREMLETG | 186 | Q92771 | |
| ILTMRSELRARLEAL | 331 | P17174 | |
| RMAARILLGLRLDEA | 191 | Q6V0L0 | |
| LQTMTLEHVLRFLRR | 41 | P48664 | |
| IAGIMLLLRSIRLTS | 46 | Q6P1S2 | |
| GVELSVRSMLDLRQL | 861 | O60336 | |
| RALRSETELLLSGKM | 1046 | Q16760 | |
| IMDLTRLRCLGSLFS | 2446 | Q14204 | |
| LELLRGSQAIMLRSA | 1131 | Q13751 | |
| STGMELLRRIQERLL | 2406 | Q8IWT3 | |
| LVRSRLLLLDTVTMQ | 841 | Q9Y678 | |
| LERMVEALRAGSARL | 141 | Q9H9S5 | |
| SRALLSLRAVREMRL | 871 | Q16478 | |
| LLTMLRTELRDYRGL | 451 | Q86YV9 | |
| ELKRSAMRAVAALLT | 1176 | O75155 | |
| ATLLREMAAGRLLEL | 1036 | Q9P225 | |
| LLAIALERSLTMARR | 126 | Q9H228 | |
| MLGTTDLLRERFSLL | 406 | Q6AZY7 | |
| SLELRAEVAMLRALL | 36 | Q8N4L8 | |
| AMAELRVVVALTLLR | 481 | Q6NT55 | |
| EAIDRSLLRSLLSML | 361 | Q13620 | |
| VLSMARLARDVLAEI | 536 | Q9HCH3 | |
| MTALELARRGARVVL | 51 | Q6UX07 | |
| RSLASRRSLINMVLD | 1091 | Q2NKX8 | |
| MGLVRRDTALLLRDF | 806 | Q05469 | |
| ILDRSSSMKSLRILL | 106 | Q99759 | |
| ENTLMILLIRSDSRL | 41 | Q8NGZ0 | |
| ALLTMRPRLLLSAAV | 171 | Q12889 | |
| SSVTRDMDILRSLIR | 236 | Q5VVY1 | |
| EERLIRLSRNMCLLL | 346 | Q8WU17 | |
| ALVMETLNEGRLRLV | 281 | Q96GQ5 | |
| RAILGSVERMIAILT | 591 | P26639 | |
| VTLLGKMERLRSSLL | 821 | A2RUB1 | |
| MLGVVLRDLSRSALL | 416 | Q9NQ40 | |
| LSDDTLLDIMRRFRA | 31 | Q2TB90 | |
| VTLSSGDMRRALNIL | 206 | P40937 | |
| ERAVMRILSGISTLL | 486 | O94761 | |
| MQRLRARGLTVDSIL | 151 | P78549 | |
| LIMDRAGRRLLLVLS | 311 | Q9NY64 | |
| ARLVRSLLDLFLDME | 86 | O00231 | |
| HIMRRGRETLLTLLE | 2401 | Q96Q15 | |
| MEQLLRAELRTATLR | 1 | Q9H479 | |
| RIIFRTSELMTLRGS | 536 | O43166 | |
| LLEMRRSVAELRLQL | 646 | Q5T5P2 | |
| LRQRMDILDVLTLAA | 606 | Q9Y4R8 | |
| ARGRLLILMEARLSA | 251 | P41252 | |
| RFLSAEAIGIMRRLL | 836 | Q16512 | |
| EMERLRFLLSDQSLL | 1036 | Q15477 | |
| ILVAIIRMRSAEGRL | 221 | Q8NGP9 | |
| LRMAAIRRASAILRS | 106 | P46779 | |
| VRQMAAALLRRLLSS | 66 | O60518 | |
| AKRVLGLLERSSMSL | 446 | Q5JPH6 | |
| RINLRGVMRSISLLE | 531 | Q8TE77 | |
| ELLRRPMDSLDSRLS | 766 | P42229 | |
| RRRQVASDLMSLLLL | 106 | Q8N326 | |
| ELLEILSFDSVRRRM | 546 | P98196 | |
| MAASRLELNLVRLLS | 1 | Q9NZ43 | |
| ELSSMVLELRGLRTI | 276 | P07996 | |
| ADVSMLRLLETFLRS | 226 | Q5GH72 | |
| RILVTLLHTLERMGR | 361 | Q9BWD1 | |
| SRAALLRLFLAMERG | 576 | Q9NRA0 | |
| LAMRRRLSFTLERLS | 2451 | Q15772 | |
| ERRIVSQLLTLMDGL | 321 | P55072 | |
| RLMQRVALDAVALAL | 336 | Q9H2B4 | |
| MATRRLTDAFLLLRN | 1 | O14662 | |
| IRLAQLEDLIGRMAT | 1276 | Q9HCF6 | |
| LEDLIGRMATALERL | 1281 | Q9HCF6 | |
| ALRLRLRGTADDMLA | 1371 | Q9P227 | |
| ALIDEDRLLSRLEVM | 206 | Q14BN4 | |
| RALAAILERRAAMLR | 156 | Q6P2H8 | |
| RSDLLAAIRMGIQLK | 441 | Q9UPY6 | |
| LDRASLDLMIRLLEL | 736 | Q7Z5K2 | |
| RALSVDMAVFRDLLR | 381 | Q9Y2I9 | |
| AMRRGLLRATTAALL | 3511 | Q15149 | |
| TIVDDLRLDILLRML | 381 | Q9UPU5 | |
| LSLREQREVLRADMS | 16 | Q9UL58 | |
| EGRRSVRLILIDLML | 166 | Q9BY10 | |
| LLLLLISESMATRDV | 346 | Q9ULT0 | |
| MAAQALALLREVARL | 1 | Q16401 | |
| MLTLLRAFEARDRNL | 171 | Q13445 | |
| RAGVSRAMLLRLFLA | 291 | Q9NYA1 | |
| LMRTASELLLDRRLR | 1641 | Q92508 | |
| ERRAMITPALREALT | 351 | Q9NV66 | |
| ATLELLGRVLRDMDL | 416 | P19438 | |
| LLSRGMARLVVIDSV | 201 | O43542 | |
| MRLGSRAEITELILQ | 436 | Q6ZT21 | |
| LIFARRIDIRMVSLD | 1051 | O75096 | |
| TLFTLEELRAQMLIR | 686 | O94832 | |
| QLLAMALRLRESAEL | 671 | Q58DX5 | |
| QVRTERMLLDLLLEA | 611 | Q14CX7 |